1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Smith, J.W.
Le Calvez, H.
Parra-Gessert, L.
Preece, N.E.
Jia, X.
Assa-Munt, N.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C2 H4 O
44.053
ACETYL GROUP
non-polymer
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
H2 N
16.023
AMINO GROUP
non-polymer
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
277
10298
10305
10.1074/jbc.M108071200
11748219
Selection and structure of ion-selective ligands for platelet integrin alpha IIb(beta) 3.
2002
10.2210/pdb1i98/pdb
pdb_00001i98
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1505.774
ION-SELECTIVE LIGAND D18
1
syn
polymer
no
yes
(ACE)CRWLRGDWRQC(NH2)
XCRWLRGDWRQCX
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conn
struct_site
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2002-07-10
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_struct_conn.pdbx_leaving_atom_flag
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
NMR Ensemble of Ion-Selective Ligand A1 for Platelet Integrin alphaIIb-beta3
NMR ENSEMBLE OF ION-SELECTIVE LIGAND A22 FOR PLATELET INTEGRIN ALPHAIIB-BETA3
NMR ENSEMBLE OF ION-SELECTIVE LIGAND D16 FOR PLATELET INTEGRIN ALPHAIIB-BETA3
RCSB
Y
RCSB
2001-03-18
REL
REL
The peptide was chemically synthesized: Commercial solid phase with cyclization with selective disulphide oxidation.
sample
THE ENSEMBLE WAS DETERMINED USING STANDARD 2D HOMONUCLEAR NMR TECHNIQUES (CIRCA 2000)
structures with the lowest energy
200
15
NOESY & DQF-COSY
10mM PHOSPHATE/5% D2O
6.50
1
atm
278.00
K
ENSEMBLE D18 IS BASED ON A TOTAL OF 70 NOE-DERIVED DISTANCE CONSTRAINTS,
8 DIHEDRAL ANGLE RESTRAINTS, 1 COVALENT ACE-CYS-SS-CYS BOND AND 1 LRGD I,I+3
HYDROGEN BOND RESPECTIVELY. REFINEMENTS INCORPORATED ALPHA PROTON AND ALPHA,
BETA CARBON SHIFTS OF 10 RESIDUES.
RESTRAINED MOLECULAR DYNAMICS AND CHEMICAL SHIFT REFINEMENT.
3MG D18/ML
BRUNGER A. NILGES M. (KUSZWESKI J. CLORE G.M.)
refinement
X-PLOR
3.8.5.1 (CHEM.SHIFT.MODULE)
VARIANINC
collection
VNMR
6.1B
HARE D. > BIOSYM > MSI
data analysis
Felix
2000
500
Varian
UNITYPLUS
ACE
1
n
1
ACE
1
A
CYS
2
n
2
CYS
2
A
ARG
3
n
3
ARG
3
A
TRP
4
n
4
TRP
4
A
LEU
5
n
5
LEU
5
A
ARG
6
n
6
ARG
6
A
GLY
7
n
7
GLY
7
A
ASP
8
n
8
ASP
8
A
TRP
9
n
9
TRP
9
A
ARG
10
n
10
ARG
10
A
GLN
11
n
11
GLN
11
A
CYS
12
n
12
CYS
12
A
CYS
12
n
13
NH2
13
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
ARG
3
0.312
SIDE CHAIN
1
A
ARG
6
0.300
SIDE CHAIN
1
A
ARG
10
0.306
SIDE CHAIN
2
A
ARG
3
0.292
SIDE CHAIN
2
A
ARG
6
0.305
SIDE CHAIN
2
A
ARG
10
0.276
SIDE CHAIN
3
A
ARG
3
0.310
SIDE CHAIN
3
A
ARG
6
0.313
SIDE CHAIN
3
A
ARG
10
0.308
SIDE CHAIN
4
A
ARG
3
0.279
SIDE CHAIN
4
A
ARG
6
0.243
SIDE CHAIN
4
A
ARG
10
0.260
SIDE CHAIN
5
A
ARG
3
0.316
SIDE CHAIN
5
A
ARG
6
0.302
SIDE CHAIN
5
A
ARG
10
0.262
SIDE CHAIN
6
A
ARG
3
0.316
SIDE CHAIN
6
A
ARG
6
0.314
SIDE CHAIN
6
A
ARG
10
0.242
SIDE CHAIN
7
A
ARG
3
0.245
SIDE CHAIN
7
A
ARG
6
0.306
SIDE CHAIN
7
A
ARG
10
0.290
SIDE CHAIN
8
A
ARG
3
0.287
SIDE CHAIN
8
A
ARG
6
0.289
SIDE CHAIN
8
A
ARG
10
0.272
SIDE CHAIN
9
A
ARG
3
0.291
SIDE CHAIN
9
A
ARG
6
0.298
SIDE CHAIN
9
A
ARG
10
0.258
SIDE CHAIN
10
A
ARG
3
0.304
SIDE CHAIN
10
A
ARG
6
0.317
SIDE CHAIN
10
A
ARG
10
0.302
SIDE CHAIN
11
A
ARG
3
0.301
SIDE CHAIN
11
A
ARG
6
0.313
SIDE CHAIN
11
A
ARG
10
0.253
SIDE CHAIN
12
A
ARG
3
0.317
SIDE CHAIN
12
A
ARG
6
0.317
SIDE CHAIN
12
A
ARG
10
0.316
SIDE CHAIN
13
A
ARG
3
0.315
SIDE CHAIN
13
A
ARG
6
0.314
SIDE CHAIN
13
A
ARG
10
0.249
SIDE CHAIN
14
A
ARG
3
0.309
SIDE CHAIN
14
A
ARG
6
0.317
SIDE CHAIN
14
A
ARG
10
0.209
SIDE CHAIN
15
A
ARG
3
0.300
SIDE CHAIN
15
A
ARG
6
0.230
SIDE CHAIN
15
A
ARG
10
0.314
SIDE CHAIN
1
A
ASP
8
-98.18
-157.49
1
A
ARG
10
-71.84
-167.33
1
A
GLN
11
-56.09
-175.82
2
A
TRP
4
-115.16
53.46
2
A
LEU
5
-91.93
52.97
2
A
ASP
8
38.41
32.89
3
A
ARG
3
-122.46
-82.88
3
A
LEU
5
-91.12
59.25
3
A
ASP
8
64.08
-151.08
3
A
ARG
10
-89.36
46.19
4
A
TRP
9
-91.35
-105.64
4
A
ARG
10
-101.36
47.50
5
A
ASP
8
55.58
-89.34
7
A
LEU
5
-112.72
64.45
7
A
ASP
8
64.89
-72.96
8
A
TRP
9
-101.11
-78.81
9
A
TRP
4
-155.86
-156.57
9
A
LEU
5
-77.76
-145.02
9
A
ASP
8
60.98
-138.74
10
A
ARG
3
-118.91
66.45
10
A
LEU
5
-101.53
53.63
10
A
ASP
8
55.92
81.38
10
A
TRP
9
-101.02
-155.79
10
A
ARG
10
-70.61
-165.56
11
A
TRP
4
-117.67
54.13
11
A
LEU
5
-115.82
52.34
12
A
LEU
5
-113.05
78.48
12
A
ASP
8
39.48
44.08
12
A
TRP
9
-78.91
-166.37
13
A
LEU
5
-100.77
66.01
14
A
ASP
8
-86.55
49.08
15
A
ASP
8
-91.47
-147.06
NMR ENSEMBLE OF ION-SELECTIVE LIGAND D18 FOR PLATELET INTEGRIN ALPHAIIB-BETA3
1
N
N
disulf
2.018
A
CYS
2
A
SG
CYS
2
1_555
A
CYS
12
A
SG
CYS
12
1_555
covale
1.309
both
A
ACE
1
A
C
ACE
1
1_555
A
CYS
2
A
N
CYS
2
1_555
covale
1.306
both
A
CYS
12
A
C
CYS
12
1_555
A
NH2
13
A
N
NH2
13
1_555
CELL ADHESION
INTEGRIN, RGD, CELL ADHESION
1I98
PDB
1
1I98
1
13
1I98
1
13
1I98
A
1
1
13
BINDING SITE FOR RESIDUE ACE A 1
A
ACE
1
Software
2
BINDING SITE FOR RESIDUE NH2 A 13
A
NH2
13
Software
1
A
ASP
8
A
ASP
8
2
1_555
A
ARG
10
A
ARG
10
2
1_555
A
CYS
12
A
CYS
12
1
1_555
1
P 1